Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$0.17 - $1.57 $6,021 - $55,614
-35,423 Reduced 37.75%
58,418 $11,000
Q4 2022

Feb 14, 2023

SELL
$1.44 - $2.29 $130,783 - $207,982
-90,822 Reduced 49.18%
93,841 $151,000
Q3 2022

Nov 14, 2022

SELL
$1.86 - $3.01 $15,756 - $25,497
-8,471 Reduced 4.39%
184,663 $386,000
Q2 2022

Aug 15, 2022

BUY
$1.46 - $3.55 $218,423 - $531,097
149,605 Added 343.69%
193,134 $408,000
Q1 2022

May 16, 2022

SELL
$2.66 - $6.63 $172,708 - $430,472
-64,928 Reduced 59.87%
43,529 $148,000
Q4 2021

Feb 14, 2022

BUY
$6.07 - $12.0 $542,967 - $1.07 Million
89,451 Added 470.65%
108,457 $658,000
Q3 2021

Nov 15, 2021

SELL
$6.79 - $13.9 $214,102 - $438,294
-31,532 Reduced 62.39%
19,006 $134,000
Q2 2021

Aug 16, 2021

SELL
$9.43 - $16.6 $700,366 - $1.23 Million
-74,270 Reduced 59.51%
50,538 $694,000
Q1 2021

May 17, 2021

BUY
$9.71 - $18.6 $824,437 - $1.58 Million
84,906 Added 212.79%
124,808 $1.34 Million
Q4 2020

Feb 16, 2021

SELL
$3.91 - $12.28 $438,850 - $1.38 Million
-112,238 Reduced 73.77%
39,902 $482,000
Q3 2020

Nov 16, 2020

BUY
$3.81 - $5.73 $481,679 - $724,415
126,425 Added 491.64%
152,140 $802,000
Q2 2020

Aug 14, 2020

BUY
$3.53 - $6.12 $50,450 - $87,467
14,292 Added 125.12%
25,715 $126,000
Q1 2020

May 14, 2020

BUY
$3.21 - $7.06 $36,667 - $80,646
11,423 New
11,423 $43,000

About Evelo Biosciences, Inc.


  • Ticker EVLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,994,000
  • Description
  • Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...
More about EVLO
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.